Specialty Diagnostics — Consolidated revenues

Business Segments · Consolidated revenues

Thermo Fisher Scientific Specialty Diagnostics — Consolidated revenues increased by 4.0% to $1.17B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.0%, from $1.13B to $1.17B. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2016
Last reportedQ3 2025
Rolls up toTotal Revenue

How to read this metric

An increase indicates strong market demand and successful product adoption, while a decrease signals market saturation or competitive pressure.

Detailed definition

The total gross income generated from the sale of diagnostic products, reagents, and services within the Specialty Diagn...

Peer comparison

Key performance indicator for all diagnostic equipment and consumable manufacturers.

Metric ID: tmo_segment_specialty_diagnostics_consolidated_revenues

Historical Data

9 periods
 Q2 '21Q1 '22Q2 '22Q1 '23Q2 '23Q3 '23Q4 '23Q3 '24Q3 '25
Value$1.24B$1.48B$1.10B$1.10B$1.10B$1.10B$1.10B$1.13B$1.17B
QoQ Change+20.0%-25.7%+0.0%+0.0%+0.0%+0.0%+2.5%+4.0%
YoY Change-10.9%-25.7%+0.0%+2.5%+4.0%
Range$1.10B$1.48B
CAGR-2.5%
Avg YoY Growth-6.0%
Median YoY Growth+0.0%
Current Streak6 quarters growth

Frequently Asked Questions

What is Thermo Fisher Scientific's specialty diagnostics — consolidated revenues?
Thermo Fisher Scientific (TMO) reported specialty diagnostics — consolidated revenues of $1.17B in Q3 2025.
How has Thermo Fisher Scientific's specialty diagnostics — consolidated revenues changed year-over-year?
Thermo Fisher Scientific's specialty diagnostics — consolidated revenues increased by 4.0% year-over-year, from $1.13B to $1.17B.
What does specialty diagnostics — consolidated revenues mean?
Total sales generated by the Specialty Diagnostics business segment.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.